{"id":"NCT01444430","sponsor":"AstraZeneca","briefTitle":"A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents","officialTitle":"A 26 Week, Randomized, Double-blind, Parallel-group, Active Controlled, Multicenter, Multinational Safety Study Evaluating the Risk of Serious Asthma-related Events During Treatment With Symbicort®, a Fixed Combination of Inhaled Corticosteroid (ICS) (Budesonide) and a Long Acting β2-agonist (LABA) (Formoterol) as Compared to Treatment With ICS (Budesonide) Alone in Adult and Adolescent (≥12 Years of Age) Patients With Asthma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-12","primaryCompletion":"2015-10","completion":"2015-10","firstPosted":"2011-09-30","resultsPosted":"2016-12-15","lastUpdate":"2016-12-15"},"enrollment":12460,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Asthma"],"interventions":[{"type":"DRUG","name":"Symbicort pMDI","otherNames":[]},{"type":"DRUG","name":"budesonide pMDI","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of the study is to evaluate the safety of Symbicort compared to inhaled corticosteroid alone during 6 months in adult and adolescent patients with asthma","primaryOutcome":{"measure":"Number of Participants Experiencing an Event in the Composite Endpoint (Asthma-related Death, Asthma-related Intubation or Asthma-related Hospitalization)","timeFrame":"Up to 27 weeks","effectByArm":[{"arm":"Symbicort","deltaMin":43,"sd":null},{"arm":"Budesonide","deltaMin":40,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":8},"locations":{"siteCount":341,"countries":["United States","Argentina","Brazil","Bulgaria","Chile","Colombia","Czechia","France","Germany","India","Italy","Mexico","Panama","Peru","Philippines","Poland","Puerto Rico","Romania","Russia","Slovakia","South Africa","South Korea","Thailand","Ukraine","United Kingdom","Vietnam"]},"refs":{"pmids":["27579635"],"seeAlso":["http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=541&filename=D5896C00027_Protocol_redacted.pdf"]},"adverseEventsSummary":{"seriousAny":{"events":125,"n":5846},"commonTop":[]}}